What they were paid
Apogee Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $87,231 | — | $399,988 | — | $487,219 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Apogee Therapeutics, Inc. DEF 14A filed April 24, 2026, accession 0001193125-26-177342, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Apogee Therapeutics pays directors a $40,000 cash retainer and $400,000 in Options.
Committees
FY2025 · as the proxy prints themCompensation (Chair) · Nominating/Governance
The rest of the Apogee Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Gottesdiener, M.D | Independent Director | $448,834 |
| Jennifer Fox | Independent Director | $464,026 |
| Lisa Bollinger, M.D | Independent Director | $444,526 |
| Michael Henderson, M.D | Director | $0 |
| Nimish Shah | Independent Director | $444,526 |
| Peter Harwin | Independent Director | $448,834 |
| Tomas Kiselak | Independent Director | $439,988 |
| William (BJ) Jones Jr | Independent Director | $455,411 |
The full Apogee Therapeutics compensation record
free company briefThis page is one director within Apogee Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat